What is Labcorp Holdings Inc.'s earnings per share (EPS)?

Labcorp Holdings Inc. (LH) reported diluted earnings per share of $10.46 for fiscal year 2025. This represents a 18.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Labcorp Holdings Inc. (LH) Financials

Trailing 12 months to June 30, 2026

Revenue $14.3B +6.4% YoY

Net Income $1.0B +31.4% YoY

EPS (Diluted) $12.09 +33.3% YoY

Free Cash Flow $1.2B -8.4% YoY

Market Cap $25.8B as of Oct 17, 2026

Price / Sales 1.8x on $14.3B revenue, trailing 12 months to June 30, 2026

Price / Earnings 25.7x on $1.0B net income, trailing 12 months to June 30, 2026

Price / Book 3.0x on $8.6B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 17, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 5, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the LH SEC filings page.

Labcorp Holdings Inc. (LH) reported $14.3B in revenue over the twelve months to Jun 30, 2026, up 6.4% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI LH FY2025 2026-10-03

Labcorp’s profit recovery is real, but cash generation has not matched earnings improvement as reinvestment remains material.

Revenue returned near its FY2021 scale by FY2025, while operating margin climbed from 6.0% in FY2023 to 9.9%. Because SG&A consumed a smaller share of revenue and gross margin also widened, the recovery reflects operating efficiency alongside renewed volume rather than volume alone.

FY2025 operating cash flow was $1.6B against net income of $877M, so cash generation exceeded accounting profit and indicates that non-cash charges and working-capital timing supported conversion. Free cash flow reached $1.2B after $435M of capital expenditures, showing that reinvestment absorbs a meaningful portion of operating cash.

The current ratio recovered to 1.4x from 1.2x in FY2023, improving short-term coverage. Debt-to-equity remained at 0.6x, above its FY2023 level, so the balance sheet is less constrained than during the downturn but still relies meaningfully on debt financing.

Financial Health Signals

Financial Health Score 50/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Labcorp Holdings Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Labcorp Holdings Inc. has an operating margin of 9.9%, meaning the company retains $10 of operating profit per $100 of revenue. This results in a moderate score of 60/100, indicating healthy but not exceptional operating efficiency. This is up from 8.3% the prior year.

Growth

Labcorp Holdings Inc.'s revenue grew 7.2% year-over-year to $14.0B, a solid pace of expansion. This earns a growth score of 57/100.

Leverage

Labcorp Holdings Inc. has elevated debt relative to equity (D/E of 0.59), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 29/100, reflecting increased financial risk.

Liquidity

Labcorp Holdings Inc.'s current ratio of 1.42 indicates adequate short-term liquidity, earning a score of 38/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Labcorp Holdings Inc. has a free cash flow margin of 8.6%, earning a moderate score of 60/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Labcorp Holdings Inc.'s ROE of 10.2% shows moderate profitability relative to equity, earning a score of 58/100. This is up from 9.3% the prior year.

Altman Z-Score Safe

3.33

Labcorp Holdings Inc. scores 3.33, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong

8/9

Labcorp Holdings Inc. passes 8 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

1.87x

For every $1 of reported earnings, Labcorp Holdings Inc. generates $1.87 in operating cash flow ($1.6B OCF vs $877.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

6.18x

Labcorp Holdings Inc. earns $6.18 in operating income for every $1 of interest expense ($1.4B vs $224.1M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$3.7B

YoY+5.8%

QoQ+5.5%

5Y CAGR-0.6%

10Y CAGR+4.4%

Labcorp Holdings Inc. generated $3.7B in revenue in Q2 2026. This represents an increase of 5.8% from the same quarter a year earlier. Against the prior quarter it is up 5.5%.

EBITDA

$630.6M

YoY+11.7%

QoQ+13.8%

5Y CAGR-6.7%

Labcorp Holdings Inc.'s EBITDA was $630.6M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 11.7% from the same quarter a year earlier. Against the prior quarter it is up 13.8%.

Net Income

$298.7M

YoY+25.6%

QoQ+7.5%

5Y CAGR-8.6%

10Y CAGR+3.9%

Labcorp Holdings Inc. reported $298.7M in net income in Q2 2026. This represents an increase of 25.6% from the same quarter a year earlier. Against the prior quarter it is up 7.5%.

EPS (Diluted)

$3.64

YoY+28.2%

QoQ+8.7%

5Y CAGR-5.2%

10Y CAGR+6.4%

Labcorp Holdings Inc. earned $3.64 per diluted share (EPS) in Q2 2026. This represents an increase of 28.2% from the same quarter a year earlier. Against the prior quarter it is up 8.7%.

Cash & Balance Sheet

Free Cash Flow

$313.9M

YoY-42.2%

QoQ+345.2%

5Y CAGR-4.2%

10Y CAGR+1.1%

Labcorp Holdings Inc. generated $313.9M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 42.2% from the same quarter a year earlier. Against the prior quarter it is up 345.2%.

Cash & Debt

$141.8M

YoY-78.1%

QoQ-85.5%

5Y CAGR-40.9%

10Y CAGR-14.0%

Labcorp Holdings Inc. held $141.8M in cash against $5.9B in long-term debt as of Q2 2026.

Dividends Per Share

$0.72

YoY0.0%

QoQ0.0%

Labcorp Holdings Inc. paid $0.72 per share in dividends in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

81M

YoY-2.4%

QoQ-1.1%

5Y CAGR-3.4%

10Y CAGR-2.3%

Labcorp Holdings Inc. had 81M shares outstanding in Q2 2026. This represents a decrease of 2.4% from the same quarter a year earlier. Against the prior quarter it is down 1.1%.

Margins & Returns

Gross Margin

29.8%

YoY+0.1pp

QoQ+1.1pp

5Y change-3.1pp

10Y change-4.2pp

Labcorp Holdings Inc.'s gross margin was 29.8% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 0.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.1 percentage points.

Operating Margin

12.1%

YoY+0.9pp

QoQ+1.3pp

5Y change-6.2pp

Labcorp Holdings Inc.'s operating margin was 12.1% in Q2 2026, reflecting core business profitability. This is up 0.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.3 percentage points.

Net Margin

8.0%

YoY+1.3pp

QoQ+0.2pp

5Y change-4.2pp

10Y change-0.4pp

Labcorp Holdings Inc.'s net profit margin was 8.0% in Q2 2026, showing the share of revenue converted to profit. This is up 1.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.2 percentage points.

Return on Equity

3.5%

YoY+0.7pp

QoQ+0.3pp

5Y change-1.1pp

10Y change-0.4pp

Labcorp Holdings Inc.'s ROE was 3.5% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.3 percentage points.

Capital Allocation

Share Buybacks

$353.8M

YoY+76.9%

QoQ+261.0%

Labcorp Holdings Inc. spent $353.8M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 76.9% from the same quarter a year earlier. Against the prior quarter it is up 261.0%.

Capital Expenditures

$131.6M

YoY+68.9%

QoQ+8.8%

5Y CAGR+6.2%

10Y CAGR+7.0%

Labcorp Holdings Inc. invested $131.6M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 68.9% from the same quarter a year earlier. Against the prior quarter it is up 8.8%.

R&D Spending

Not reported for Q2 2026.

LH Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

LH quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$14.3B	$14.0B+7.2%	$13.0B+7.0%	$12.2B+2.5%	$11.9B-9.7%	$13.1B-6.0%	$14.0B+21.0%	$11.6B+2.0%	$11.3B+9.9%	$10.3B+7.9%	$9.6B+10.1%	$8.7B+44.4%	$6.0B+3.5%	$5.8B+2.4%	$5.7B+2.3%	$5.5B
Cost of Revenue	$10.2B	$9.9B+5.9%	$9.4B+6.7%	$8.8B+7.9%	$8.2B+0.1%	$8.1B-9.8%	$9.0B+8.7%	$8.3B+1.8%	$8.2B+21.0%	$6.7B+7.8%	$6.3B+11.7%	$5.6B+47.1%	$3.8B+6.2%	$3.6B+4.8%	$3.4B+4.7%	$3.3B
Gross Profit	$4.1B	$4.0B+10.7%	$3.6B+7.7%	$3.4B-9.3%	$3.7B-25.7%	$5.0B+0.8%	$5.0B+52.3%	$3.3B+2.4%	$3.2B+2.7%	$3.1B+8.3%	$2.9B-1.7%	$2.9B+31.8%	$2.2B-0.9%	$2.2B-1.2%	$2.2B-1.1%	$2.3B
SG&A Expenses	$2.2B	$2.2B-0.6%	$2.2B+10.3%	$2.0B+14.7%	$1.8B+4.3%	$1.7B-2.3%	$1.7B+6.5%	$1.6B+3.4%	$1.6B+4.8%	$1.5B+11.4%	$1.3B-17.4%	$1.6B+35.9%	$1.2B+6.1%	$1.1B+1.3%	$1.1B-3.9%	$1.2B
Operating Income	$1.5B	$1.4B+27.4%	$1.1B+49.8%	$725.6M-49.5%	$1.4B-52.9%	$3.0B+24.7%	$2.4B+83.8%	$1.3B+0.3%	$1.3B+1.6%	$1.3B+2.7%	$1.3B+27.5%	$996.8M+9.5%	$910.4M-8.1%	$990.9M-3.2%	$1.0B+7.9%	$948.4M
EBITDA	N/A	$2.1B+19.4%	$1.7B+32.8%	$1.3B-34.0%	$2.0B-45.6%	$3.6B+18.1%	$3.1B+61.0%	$1.9B+1.6%	$1.9B+2.1%	$1.8B+3.9%	$1.8B+21.7%	$1.5B+25.8%	$1.2B-5.3%	$1.2B-2.6%	$1.3B+6.2%	$1.2B
Interest Expense	$227.2M	$224.1M+7.6%	$208.3M+4.4%	$199.6M+11.0%	$179.8M-15.1%	$211.8M+2.1%	$207.4M-13.8%	$240.7M-1.4%	$244.2M+3.9%	$235.1M+7.3%	$219.1M-20.3%	$274.9M+151.1%	$109.5M+13.5%	$96.5M+2.1%	$94.5M+8.0%	$87.5M
Income Tax	$230.2M	$229.8M+8.2%	$212.4M+12.7%	$188.5M-19.4%	$233.9M-66.1%	$690.0M+4.2%	$662.1M+136.5%	$280.0M-27.2%	$384.4M+347.4%	-$155.4M-143.1%	$360.7M+25.5%	$287.3M-8.5%	$314.1M-7.7%	$340.2M-5.3%	$359.4M+7.9%	$333.0M
Net Income	$1.0B	$877.0M+17.6%	$746.0M+78.5%	$418.0M-67.3%	$1.3B-46.2%	$2.4B+52.8%	$1.6B+88.9%	$823.8M-6.8%	$883.7M-28.0%	$1.2B+72.4%	$711.8M+62.7%	$437.6M-14.4%	$511.2M-10.9%	$573.8M-1.6%	$583.1M+12.2%	$519.7M
EPS (Basic)	N/A	$10.54+18.6%	$8.89+85.2%	$4.80-65.8%	$14.05-42.9%	$24.60+53.8%	$15.99+89.9%	$8.42-3.3%	$8.71-27.4%	$11.99+72.8%	$6.94+56.7%	$4.43-26.5%	$6.03-5.2%	$6.36+4.4%	$6.09+17.1%	$5.20
EPS (Diluted)	$12.09	$10.46+18.3%	$8.84+85.3%	$4.77-65.9%	$13.97-42.7%	$24.39+53.6%	$15.88+90.2%	$8.35-3.0%	$8.61-27.1%	$11.81+73.2%	$6.82+56.8%	$4.35-26.4%	$5.91-5.4%	$6.25+4.3%	$5.99+17.2%	$5.11
Diluted Shares (Avg)	N/A	84M-0.7%	84M-3.7%	88M-4.4%	92M-6.1%	98M-0.5%	98M-0.6%	99M-3.9%	103M-1.3%	104M-0.4%	104M+3.7%	101M+16.4%	86M-5.9%	92M-5.7%	97M-4.3%	102M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$3.7B+5.8%	$3.5B+5.8%	$3.5B+5.6%	$3.6B+8.6%	$3.5B+9.5%	$3.3B+5.3%	$3.3B+9.8%	$3.3B+7.4%
Cost of Revenue	$2.6B+5.6%	$2.5B+5.3%	$2.5B+3.7%	$2.5B+6.8%	$2.5B+8.1%	$2.4B+5.2%	$2.4B+10.0%	$2.4B+7.8%
Gross Profit	$1.1B+6.3%	$1.0B+6.9%	$993.2M+10.8%	$1.0B+13.3%	$1.0B+12.9%	$948.0M+5.7%	$896.3M+9.1%	$904.4M+6.3%
SG&A Expenses	$577.2M-0.4%	$551.0M+0.9%	$538.6M-9.5%	$552.4M-2.8%	$579.3M+3.9%	$546.0M+7.4%	$595.2M+11.7%	$568.6M+8.2%
Operating Income	$451.6M+14.5%	$380.8M+16.8%	$267.6M+23.6%	$396.6M+56.1%	$394.5M+33.8%	$326.0M+1.5%	$216.5M+276.3%	$254.1M+0.7%
EBITDA	$630.6M+11.7%	$554.1M+12.4%	$440.6M+13.8%	$567.6M+36.6%	$564.8M+25.0%	$492.8M+3.6%	$387.1M+1540.3%	$415.6M+4.4%
Interest Expense	$61.1M+7.0%	$55.1M-1.6%	$55.0M-13.2%	$56.0M+11.1%	$57.1M+20.0%	$56.0M+19.4%	$63.4M+29.9%	$50.4M+0.2%
Income Tax	$87.3M+31.5%	$41.7M-33.0%	$25.7M-36.1%	$75.5M+84.1%	$66.4M+6.9%	$62.2M-10.0%	$40.2M+104.1%	$41.0M-25.6%
Net Income	$298.7M+25.6%	$277.8M+30.5%	$165.2M+15.2%	$261.1M+54.2%	$237.9M+15.9%	$212.8M-6.7%	$143.4M+185.8%	$169.3M-7.6%
EPS (Basic)	$3.66+28.4%	$3.37+32.7%	$2.00+16.3%	$3.14+55.4%	$2.85+16.8%	$2.54-6.3%	$1.72+192.5%	$2.02-4.7%
EPS (Diluted)	$3.64+28.2%	$3.35+32.9%	$1.98+15.8%	$3.12+56.0%	$2.84+16.9%	$2.52-6.3%	$1.71+191.9%	$2.00-5.2%
Diluted Shares (Avg)	82M-2.3%	83M-1.7%	N/A	84M-0.8%	84M-0.5%	84M-0.5%	N/A	84M-3.0%

Not reported in any period shown, so not listed: R&D Expenses.

LH Balance Sheet

LH quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$18.4B+0.1%	$18.4B+9.9%	$16.7B-17.0%	$20.2B-1.1%	$20.4B+1.6%	$20.1B+11.2%	$18.0B+11.5%	$16.2B-2.9%	$16.7B+17.0%	$14.2B+1.0%	$14.1B+93.2%	$7.3B+4.8%	$7.0B+2.5%	$6.8B+11.2%	$6.1B
Current Assets	$4.0B-16.4%	$4.8B+27.6%	$3.8B-18.6%	$4.6B-13.2%	$5.3B+4.0%	$5.1B+71.9%	$3.0B+5.1%	$2.8B+3.7%	$2.7B+10.3%	$2.5B-5.4%	$2.6B+54.9%	$1.7B+18.2%	$1.4B+2.9%	$1.4B+31.3%	$1.1B
Cash & Equivalents	$532.3M-65.0%	$1.5B+182.9%	$536.8M+67.4%	$320.6M-78.2%	$1.5B+11.5%	$1.3B+291.3%	$337.5M-20.9%	$426.8M+34.8%	$316.6M-27.0%	$433.6M-39.5%	$716.4M+23.5%	$580.0M+43.6%	$404.0M0.0%	$404.0M-13.5%	$466.8M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$534.7M+8.4%	$493.2M+3.9%	$474.6M+0.8%	$470.6M+17.2%	$401.4M-5.2%	$423.2M+72.9%	$244.7M+3.1%	$237.3M+4.4%	$227.2M+10.7%	$205.2M+7.4%	$191.0M+36.9%	$139.5M+2.2%	$136.5M+12.8%	$121.0M+9.2%	$110.8M
Accounts Receivable	$2.1B+8.2%	$1.9B+1.6%	$1.9B+7.2%	$1.8B-21.0%	$2.3B-8.8%	$2.5B+60.6%	$1.5B+5.2%	$1.5B-4.1%	$1.5B+15.2%	$1.3B+9.1%	$1.2B+49.3%	$815.7M+4.0%	$784.7M+9.2%	$718.5M+2.7%	$699.8M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$6.8B+6.6%	$6.4B+3.7%	$6.1B+0.3%	$6.1B+4.0%	$5.9B-24.0%	$7.8B-1.4%	$7.9B+6.9%	$7.4B-0.5%	$7.4B+15.2%	$6.4B0.0%	$6.4B+3.6%	$6.2B+105.2%	$3.0B+4.2%	$2.9B+8.2%	$2.7B
Total Liabilities	$9.8B-5.4%	$10.3B+16.7%	$8.8B-12.0%	$10.0B-0.5%	$10.1B-4.9%	$10.6B+1.5%	$10.5B+13.8%	$9.2B-6.6%	$9.8B+12.9%	$8.7B-4.6%	$9.1B+104.9%	$4.5B+0.2%	$4.5B+140.8%	$1.8B-48.4%	$3.6B
Current Liabilities	$2.8B-15.2%	$3.3B+3.3%	$3.2B+4.8%	$3.1B+10.6%	$2.8B-9.6%	$3.1B+15.9%	$2.7B+41.3%	$1.9B-14.0%	$2.2B+19.6%	$1.8B+7.5%	$1.7B+74.2%	$976.3M+32.7%	$735.7M-28.5%	$1.0B+40.4%	$732.6M
Non-Current Liabilities	$6.9B-0.7%	$7.0B+24.5%	$5.6B-19.4%	$7.0B-4.8%	$7.3B-3.0%	$7.5B-3.4%	$7.8B+6.7%	$7.3B-4.5%	$7.7B+11.1%	$6.9B-7.3%	$7.4B+113.5%	$3.5B-6.2%	$3.7B+352.8%	$821.4M-71.2%	$2.9B
Long-Term Debt	$5.1B-4.6%	$5.3B+31.5%	$4.1B-19.5%	$5.0B-7.0%	$5.4B0.0%	$5.4B-6.4%	$5.8B-3.4%	$6.0B-5.6%	$6.3B+19.7%	$5.3B-10.8%	$5.9B+121.4%	$2.7B-7.1%	$2.9B	N/A	$2.1B
Total Equity	$8.6B+7.0%	$8.1B+2.3%	$7.9B-22.0%	$10.1B-1.7%	$10.3B+8.9%	$9.4B+23.5%	$7.6B+8.5%	$7.0B+3.6%	$6.8B+23.3%	$5.5B+11.6%	$4.9B+75.3%	$2.8B+13.2%	$2.5B-49.6%	$4.9B+97.5%	$2.5B
Retained Earnings	$8.6B+4.1%	$8.3B+5.3%	$7.9B-25.5%	$10.6B+1.2%	$10.5B+10.3%	$9.5B+18.8%	$8.0B+11.5%	$7.2B+15.5%	$6.2B+24.7%	$5.0B+17.6%	$4.2B+11.6%	$3.8B+12.2%	$3.4B-20.1%	$4.2B+24.7%	$3.4B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$18.5B+2.6%	$19.1B+8.4%	$18.4B+0.1%	$18.3B-1.9%	$18.1B+8.1%	$17.6B+6.5%	$18.4B+9.9%	$18.6B+10.2%
Current Assets	$3.8B-6.7%	$4.6B+20.3%	$4.0B-16.4%	$4.1B-16.9%	$4.1B+14.4%	$3.8B+9.6%	$4.8B+27.6%	$4.9B+24.2%
Cash & Equivalents	$141.8M-78.1%	$981.1M+165.6%	$532.3M-65.0%	$598.1M-60.6%	$647.3M+144.2%	$369.4M+272.0%	$1.5B+182.9%	$1.5B+108.4%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$562.2M+10.6%	$497.7M+1.9%	$534.7M+8.4%	$521.5M+7.9%	$508.1M+15.0%	$488.3M+2.8%	$493.2M+3.9%	$483.1M+4.8%
Accounts Receivable	$2.3B+10.5%	$2.3B+7.8%	$2.1B+8.2%	$2.1B+2.5%	$2.1B+1.5%	$2.1B+1.9%	$1.9B+1.6%	$2.1B+5.2%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$7.0B+7.3%	$7.0B+8.3%	$6.8B+6.6%	$6.7B+3.1%	$6.6B+5.3%	$6.4B+3.3%	$6.4B+3.7%	$6.5B+2.4%
Total Liabilities	$9.9B+3.5%	$10.3B+11.4%	$9.8B-5.4%	$9.5B-8.4%	$9.6B+10.1%	$9.3B+8.5%	$10.3B+16.7%	$10.4B+15.9%
Current Liabilities	$2.1B-21.8%	$2.6B+27.9%	$2.8B-15.2%	$2.6B-22.9%	$2.7B-33.2%	$2.1B-47.6%	$3.3B+3.3%	$3.4B+17.6%
Non-Current Liabilities	$7.8B+13.6%	$7.7B+6.7%	$6.9B-0.7%	$6.9B-1.4%	$6.9B+48.1%	$7.2B+56.4%	$7.0B+24.5%	$7.0B+15.1%
Long-Term Debt	$5.9B+15.4%	$5.8B+4.8%	$5.1B-4.6%	$5.1B-5.0%	$5.1B+66.6%	$5.6B+82.7%	$5.3B+31.5%	$5.4B+20.9%
Total Equity	$8.6B+1.6%	$8.7B+5.1%	$8.6B+7.0%	$8.7B+6.4%	$8.5B+5.8%	$8.3B+4.4%	$8.1B+2.3%	$8.2B+3.8%
Retained Earnings	$8.7B+2.4%	$8.8B+3.9%	$8.6B+4.1%	$8.7B+5.1%	$8.5B+3.9%	$8.5B+5.0%	$8.3B+5.3%	$8.3B+2.6%

LH Cash Flow Statement

LH quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$1.6B	$1.6B+3.4%	$1.6B+19.4%	$1.3B-32.1%	$2.0B-37.1%	$3.1B+45.6%	$2.1B+47.8%	$1.4B+10.7%	$1.3B-12.9%	$1.5B+25.1%	$1.2B+21.9%	$982.4M+32.9%	$739.0M-9.7%	$818.7M-2.7%	$841.4M-1.7%	$855.6M
Depreciation & Amortization	N/A	$681.1M+5.8%	$643.5M+11.5%	$577.3M+7.5%	$537.2M-6.9%	$577.0M-7.6%	$624.7M+8.2%	$577.2M+4.5%	$552.1M+3.5%	$533.2M+6.8%	$499.2M+9.0%	$457.8M+86.5%	$245.5M+6.7%	$230.1M+0.1%	$229.8M-0.7%	$231.4M
Stock-Based Compensation	N/A	$125.8M+7.8%	$116.7M-9.3%	$128.7M+10.2%	$116.8M-12.1%	$132.9M+19.0%	$111.7M+4.4%	$107.0M+16.8%	$91.6M-16.5%	$109.7M+0.1%	$109.6M+7.3%	$102.1M+123.4%	$45.7M+22.5%	$37.3M-8.4%	$40.7M-16.8%	$48.9M
Capital Expenditures	$483.2M	$434.5M-11.3%	$489.9M+8.0%	$453.6M+5.7%	$429.3M+1.9%	$421.5M+10.4%	$381.7M-4.6%	$400.2M+5.4%	$379.8M+21.4%	$312.9M+12.2%	$278.9M+9.0%	$255.8M+25.7%	$203.5M+0.6%	$202.2M+16.3%	$173.8M+19.3%	$145.7M
Free Cash Flow	$1.2B	$1.2B+10.0%	$1.1B+25.4%	$874.1M-42.7%	$1.5B-43.2%	$2.7B+53.3%	$1.8B+67.9%	$1.0B+12.8%	$925.6M-21.9%	$1.2B+29.1%	$918.2M+26.4%	$726.6M+35.7%	$535.5M-13.1%	$616.5M-7.7%	$667.6M-6.0%	$709.9M
Investing Cash Flow	-$1.5B	-$1.2B+12.6%	-$1.4B-16.7%	-$1.2B+29.1%	-$1.7B-86.8%	-$884.6M-37.5%	-$643.2M+49.9%	-$1.3B-720.8%	$206.7M+109.3%	-$2.2B-180.1%	-$795.7M+80.1%	-$4.0B-1041.1%	-$350.1M+2.6%	-$359.6M+32.7%	-$534.2M-90.6%	-$280.3M
Financing Cash Flow	-$689.3M	-$1.5B-286.8%	$779.9M+1415.2%	-$59.3M+95.5%	-$1.3B+36.0%	-$2.1B-299.3%	-$517.4M-104.7%	-$252.7M+81.8%	-$1.4B-334.3%	$593.2M+188.4%	-$671.0M-121.1%	$3.2B+1687.5%	-$200.6M+61.3%	-$518.3M-64687.5%	-$800K+99.9%	-$645.0M
Dividends Paid	$239.6M	$240.7M-1.0%	$243.1M-4.3%	$254.0M+30.1%	$195.2M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$701.8M	$450.0M+79.9%	$250.1M-75.0%	$1.0B-9.1%	$1.1B-34.1%	$1.7B+1568.5%	$100.0M-77.8%	$450.0M-35.7%	$700.0M+107.0%	$338.1M+670.2%	$43.9M	$0-100.0%	$269.0M-73.5%	$1.0B+96.6%	$516.5M-19.8%	$643.9M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$445.5M-28.2%	$191.5M+935.1%	$614.2M-21.0%	$387.2M+39.6%	$620.6M+10.6%	$18.5M+162.1%	$777.2M+34.1%	$277.3M+0.7%
Depreciation & Amortization	$179.0M+5.1%	$173.3M+3.9%	$173.0M+1.4%	$171.0M+5.9%	$170.3M+8.5%	$166.8M+8.0%	$170.6M+16.5%	$161.5M+10.7%
Stock-Based Compensation	N/A	$31.7M-3.4%	N/A	N/A	N/A	$32.8M+3.8%	N/A	N/A
Capital Expenditures	$131.6M+68.9%	$121.0M-4.0%	$123.9M+10.5%	$106.7M-7.9%	$77.9M-39.2%	$126.0M-5.8%	$112.1M-33.0%	$115.8M+10.4%
Free Cash Flow	$313.9M-42.2%	$70.5M+165.6%	$490.3M-26.3%	$280.5M+73.7%	$542.7M+25.4%	-$107.5M+34.3%	$665.1M+61.3%	$161.5M-5.3%
Investing Cash Flow	-$366.2M-289.2%	-$322.1M+4.1%	-$389.9M-86.0%	-$374.0M+35.4%	-$94.1M+49.1%	-$336.0M+14.5%	-$209.6M+36.6%	-$579.1M-18.8%
Financing Cash Flow	-$919.9M-244.0%	$580.5M+169.1%	-$290.4M+46.9%	-$59.5M-103.8%	-$267.4M-27.3%	-$839.7M-7076.9%	-$546.7M-22.4%	$1.5B+241.1%
Dividends Paid	$58.4M-3.0%	$61.2M-0.6%	$59.3M-1.3%	$60.7M-0.7%	$60.2M0.0%	$61.6M-0.8%	$60.1M-1.6%	$61.1M-5.4%
Share Buybacks	$353.8M+76.9%	$98.0M	$225.0M+199.6%	$25.0M-66.7%	$200.0M	$0	$75.1M+734.4%	$75.0M-92.6%

LH Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

LH quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	28.8%+0.9pp	27.9%+0.2pp	27.7%-3.6pp	31.3%-6.8pp	38.0%+2.6pp	35.4%+7.3pp	28.1%+0.1pp	28.0%-2.0pp	30.0%+0.1pp	29.9%-3.6pp	33.5%-3.2pp	36.6%-1.6pp	38.3%-1.4pp	39.7%-1.4pp	41.0%
Operating Margin	9.9%+1.6pp	8.3%+2.4pp	6.0%-6.1pp	12.1%-11.1pp	23.2%+5.7pp	17.5%+6.0pp	11.5%-0.2pp	11.7%-1.0pp	12.7%-0.6pp	13.3%+1.8pp	11.5%-3.7pp	15.1%-1.9pp	17.1%-1.0pp	18.1%+0.9pp	17.1%
Net Margin	6.3%+0.6pp	5.7%+2.3pp	3.4%-7.3pp	10.8%-7.3pp	18.1%+7.0pp	11.1%+4.0pp	7.1%-0.7pp	7.8%-4.1pp	11.9%+4.5pp	7.4%+2.4pp	5.0%-3.5pp	8.5%-1.4pp	9.9%-0.4pp	10.3%+0.9pp	9.4%
Return on Equity	10.2%+0.9pp	9.3%+4.0pp	5.3%-7.4pp	12.7%-10.5pp	23.1%+6.7pp	16.5%+5.7pp	10.8%-1.8pp	12.5%-5.5pp	18.0%+5.1pp	12.9%+4.1pp	8.8%-9.3pp	18.1%-4.9pp	23.0%+11.2pp	11.8%-9.0pp	20.8%
Return on Assets	4.8%+0.7pp	4.1%+1.6pp	2.5%-3.9pp	6.3%-5.3pp	11.7%+3.9pp	7.8%+3.2pp	4.6%-0.9pp	5.5%-1.9pp	7.4%+2.4pp	5.0%+1.9pp	3.1%-3.9pp	7.0%-1.2pp	8.2%-0.3pp	8.6%+0.1pp	8.5%
Current Ratio	1.420.0x	1.44+0.3x	1.17-0.3x	1.50-0.4x	1.92+0.3x	1.66+0.5x	1.12-0.4x	1.51+0.3x	1.25-0.1x	1.36-0.2x	1.54-0.2x	1.73-0.2x	1.95+0.6x	1.35-0.1x	1.45
Debt-to-Equity	0.59-0.1x	0.66+0.1x	0.510.0x	0.500.0x	0.530.0x	0.57-0.2x	0.76-0.1x	0.85-0.1x	0.930.0x	0.96-0.2x	1.20+0.3x	0.95-0.2x	1.16+0.8x	0.37-0.5x	0.83
Asset Turnover	0.76+0.1x	0.710.0x	0.73+0.1x	0.59-0.1x	0.64-0.1x	0.70+0.1x	0.64-0.1x	0.70+0.1x	0.62-0.1x	0.67+0.1x	0.62-0.2x	0.820.0x	0.830.0x	0.83-0.1x	0.91
FCF Margin	8.6%+0.2pp	8.4%+1.2pp	7.2%-5.7pp	12.9%-7.6pp	20.5%+7.9pp	12.5%+3.5pp	9.0%+0.9pp	8.2%-3.3pp	11.5%+1.9pp	9.6%+1.2pp	8.4%-0.5pp	8.9%-1.7pp	10.6%-1.2pp	11.8%-1.0pp	12.8%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	29.8%+0.1pp	28.7%+0.3pp	28.2%+1.3pp	28.8%+1.2pp	29.7%+0.9pp	28.3%+0.1pp	26.9%-0.2pp	27.6%-0.3pp
Operating Margin	12.1%+0.9pp	10.8%+1.0pp	7.6%+1.1pp	11.1%+3.4pp	11.2%+2.0pp	9.8%-0.4pp	6.5%+10.6pp	7.7%-0.5pp
Net Margin	8.0%+1.3pp	7.8%+1.5pp	4.7%+0.4pp	7.3%+2.2pp	6.7%+0.4pp	6.4%-0.8pp	4.3%+9.8pp	5.2%-0.8pp
Return on Equity	3.5%+0.7pp	3.2%+0.6pp	1.9%+0.1pp	3.0%+0.9pp	2.8%+0.2pp	2.6%-0.3pp	1.8%+3.9pp	2.1%-0.3pp
Return on Assets	1.6%+0.3pp	1.5%+0.3pp	0.9%+0.1pp	1.4%+0.5pp	1.3%+0.1pp	1.2%-0.2pp	0.8%+1.8pp	0.9%-0.2pp
Current Ratio	1.80+0.3x	1.73-0.1x	1.420.0x	1.55+0.1x	1.50+0.6x	1.84+1.0x	1.44+0.3x	1.44+0.1x
Debt-to-Equity	0.68+0.1x	0.670.0x	0.59-0.1x	0.58-0.1x	0.60+0.2x	0.67+0.3x	0.66+0.1x	0.66+0.1x
Asset Turnover	0.200.0x	0.190.0x	0.190.0x	0.200.0x	0.200.0x	0.190.0x	0.180.0x	0.180.0x
FCF Margin	8.4%-7.0pp	2.0%+5.2pp	14.0%-6.0pp	7.9%+3.0pp	15.4%+2.0pp	-3.2%+1.9pp	20.0%+6.4pp	4.9%-0.7pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Labcorp Holdings Inc. LH	FY2025	$14.0B	$877.0M	6.3%	$25.8B	50/100
Quest Diagnostics Inc. DGX	FY2025	$11.0B	$992.0M	9.0%	$25.9B	54/100
Natera, Inc. NTRA	FY2025	$2.3B	-$208.2M	-9.0%	$56.7B	52/100
Mettler-Toledo International MTD	FY2025	$4.0B	$869.2M	21.6%	$32.5B	27/100
Waters Corp WAT	FY2025	$3.2B	$642.6M	20.3%	$42.9B	71/100
IQVIA Holdings Inc. IQV	FY2025	$16.3B	$1.4B	8.3%	$43.9B	50/100

Where Labcorp Holdings Inc. Ranks

Frequently Asked Questions

What is Labcorp Holdings Inc.'s annual revenue?

Labcorp Holdings Inc. (LH) reported $14.0B in total revenue for fiscal year 2025. This represents a 7.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Labcorp Holdings Inc.'s revenue growing?

Labcorp Holdings Inc. (LH) revenue grew by 7.2% year-over-year, from $13.0B to $14.0B in fiscal year 2025.

Is Labcorp Holdings Inc. profitable?

Yes, Labcorp Holdings Inc. (LH) reported a net income of $877.0M in fiscal year 2025, with a net profit margin of 6.3%.

What is Labcorp Holdings Inc.'s EBITDA?

Labcorp Holdings Inc. (LH) had EBITDA of $2.1B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Labcorp Holdings Inc. have?

As of fiscal year 2025, Labcorp Holdings Inc. (LH) had $532.3M in cash and equivalents against $5.1B in long-term debt.

What is Labcorp Holdings Inc.'s gross margin?

Labcorp Holdings Inc. (LH) had a gross margin of 28.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Labcorp Holdings Inc.'s operating margin?

Labcorp Holdings Inc. (LH) had an operating margin of 9.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Labcorp Holdings Inc.'s net profit margin?

Labcorp Holdings Inc. (LH) had a net profit margin of 6.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Labcorp Holdings Inc. pay dividends?

Yes, Labcorp Holdings Inc. (LH) paid $2.88 per share in dividends during fiscal year 2025.

What is Labcorp Holdings Inc.'s return on equity (ROE)?

Labcorp Holdings Inc. (LH) has a return on equity of 10.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Labcorp Holdings Inc.'s free cash flow?

Labcorp Holdings Inc. (LH) generated $1.2B in free cash flow during fiscal year 2025. This represents a 10.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Labcorp Holdings Inc.'s operating cash flow?

Labcorp Holdings Inc. (LH) generated $1.6B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Labcorp Holdings Inc.'s total assets?

Labcorp Holdings Inc. (LH) had $18.4B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Labcorp Holdings Inc.'s capital expenditures?

Labcorp Holdings Inc. (LH) invested $434.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Labcorp Holdings Inc. buy back shares?

Yes, Labcorp Holdings Inc. (LH) spent $450.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Labcorp Holdings Inc. have outstanding?

Labcorp Holdings Inc. (LH) had 82M shares outstanding as of fiscal year 2025.

What is Labcorp Holdings Inc.'s current ratio?

Labcorp Holdings Inc. (LH) had a current ratio of 1.42 as of fiscal year 2025, which is considered adequate.

What is Labcorp Holdings Inc.'s debt-to-equity ratio?

Labcorp Holdings Inc. (LH) had a debt-to-equity ratio of 0.59 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Labcorp Holdings Inc.'s return on assets (ROA)?

Labcorp Holdings Inc. (LH) had a return on assets of 4.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Labcorp Holdings Inc.'s P/E ratio?

Labcorp Holdings Inc. (LH) trades at 25.7x earnings, its market capitalization divided by net income of $1.0B net income, trailing 12 months to June 30, 2026. The market capitalization is $25.8B as of Oct 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Labcorp Holdings Inc.'s price-to-sales ratio?

Labcorp Holdings Inc. (LH) trades at 1.8x sales, its market capitalization divided by revenue of $14.3B revenue, trailing 12 months to June 30, 2026. The market capitalization is $25.8B as of Oct 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Labcorp Holdings Inc.'s Altman Z-Score?

Labcorp Holdings Inc. (LH) has an Altman Z-Score of 3.33, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Labcorp Holdings Inc.'s Piotroski F-Score?

Labcorp Holdings Inc. (LH) has a Piotroski F-Score of 8 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Labcorp Holdings Inc.'s earnings high quality?

Labcorp Holdings Inc. (LH) has an earnings quality ratio of 1.87x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Labcorp Holdings Inc. cover its interest payments?

Labcorp Holdings Inc. (LH) has an interest coverage ratio of 6.18x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Labcorp Holdings Inc.?

Labcorp Holdings Inc. (LH) scores 50 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.